Trials / Completed
CompletedNCT02361216
Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest
Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp or Approximately 250 cm2 on the Chest
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 729 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of the trial is to investigate efficacy and safety of ingenol mebutate gel for actinic keratosis applied to large treatment areas once daily for three consecutive days on face, scalp or chest.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ingenol Mebutate | |
| OTHER | Vehicle | Vehicle gel |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-03-01
- Completion
- 2017-03-01
- First posted
- 2015-02-11
- Last updated
- 2025-03-10
- Results posted
- 2018-10-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02361216. Inclusion in this directory is not an endorsement.